Epitracker

Epitracker is a biotechnology company focused on identifying and developing novel therapeutic compounds derived from comparative biology, specifically leveraging insights from long-lived marine mammals. The company's discovery platform identified C15:0 (pentadecanoic acid) as an essential fatty acid that plays a critical role in metabolic health and longevity. Through its spin-off, Seraphina Therapeutics, the company has commercialized C15:0 as a cellular health supplement while continuing to explore its potential in treating metabolic and inflammatory diseases. Epitracker's research emphasizes the intersection of marine science and human medicine to address chronic conditions such as fatty liver disease and metabolic syndrome.